RegenOMedix, a division of Zizion Group is focused on providing state of the art Regenerative Therapies and Solutions for the medical industry. Our team works
with vendors and suppliers from around the world to identify efficacious and safe devices that rely on more natural, integrative, organic, autologous, allograft type solutions versus a heavy use of drugs.
The past few years have seen significant changes on how patients are being treated. From PRP (Platelet Rich Plasma) all the way to CRISPR and CAS-9, we are learning how to best treat patients and very often the use of autologous or allograft products prove to be the best solutions with very little downside risk.